Research publications

The impact of pulmonary rehabilitation on 24-hour movement behaviour in people with chronic obstructive pulmonary disease: New insights from a compositional perspective

Burge AT, Palarea-Albaladejo J, Holland AE, Abramson MJ, McDonald CF, Mahal A, Hill CJ, Lee AL, Cox NS, Lahham A, Moore R, Nicolson C, O'Halloran P, Gillies R, Chastin SF

(2021), J Phys Act Health, 18(1), 13-20

DOI: 10.1123/jpah.2020-0322

Surf's up, radical approaches to riding the COVID-19 waves: A lung transplant perspective

Burke D, Martin R, Wilson K, Bourne B, Levvey B, Stedman H, Levin K, Ivulich S, Harris J, Miller J, Gillot J, Ndiweni N, Yates E, Vazirani J, Snell G, Westall G

(2021), Transplant Journal of Australasia, 30(1), 16-22

DOI: 10.33235/tja.30.1.3

Surgery first' if cure is your aim in CTEPH

Williams TJ, McGiffin D

(2021), Respirology, 26(2), 140-2

DOI: 10.1111/resp.13956.

INPP4B promotes PI3Kα-dependent late endosome formation and Wnt/β-catenin signaling in breast cancer

Rodgers SJ, Ooms LM, Oorschot VMJ, Schittenhelm RB, Nguyen EV, Hamila SA, Rynkiewicz N, Gurung R, Eramo MJ, Sriratana A, Fedele CG, Caramia F, Loi S, Kerr G, Abud HE, Ramm G, Papa A, Ellisdon AM, Daly RJ, McLean CA, Mitchell CA

(2021), Nat Commun, 12(1), 3140

DOI: 10.1038/s41467-021-23241-6

A simplified (modified) Duke Activity Status Index (M-DASI) to characterise functional capacity: a secondary analysis of the Measurement of Exercise Tolerance before Surgery (METS) study

Riedel B, Li MH, Lee CHA, Ismail H, Cuthbertson BH, Wijeysundera DN, Ho KM; METS Study Investigators

(2021), BRIT J ANAESTH, 126(1), 181-90

DOI: 10.1016/j.bja.2020.06.016

Principles for setting air quality guidelines to protect human health in Australia

Zosky GR, Vander Hoorn S, Abramson MJ, Dwyer S, Green D, Heyworth J, Jalaludin BB, McCrindle-Fuchs J, Tham R, Marks GB

(2021), MED J AUSTRALIA, 214(6), 254-56.e1

DOI: 10.5694/mja2.50964

Effect of Follow-Up Surveillance After Curative-Intent Treatment of NSCLC on Detection of New and Recurrent Disease, Retreatment, and Survival: A Systematic Review and Meta-Analysis

Stirling RG, Chau C, Shareh A, Zalcberg J, Fischer BM

(2021), J Thorac Oncol, 16(5), 784-97

DOI: 10.1016/j.jtho.2021.01.1622

Sleep-Disordered Breathing and Nocturnal Hypoxemia in Precapillary Pulmonary Hypertension: Prevalence, Pathophysiological Determinants, and Clinical Consequences

Spiesshoefer J, Herkenrath S, Harre K, Kahles F, Florian A, Yilmaz A, Mohr M, Naughton M, Randerath W, Emdin M, Passino C, Regmi B, Dreher M, Boentert M, Giannoni A

(2021), Respiration, 100(9), 865-76

DOI: 10.1159/000515602

Referral criteria to palliative care for patients with respiratory disease: a systematic review

Philip J, Collins A, Smallwood N, Chang YK, Mo L, Yang IA, Corte T, McDonald CF, Hui D

(2021), Eur Respir J, 58(4), 2004307

DOI: 10.1183/13993003.04307-2020

Improving the predictability of time to death in controlled donation after circulatory death lung donors

Okahara S, Snell GI, McDonald M, D'Costa R, Opdam H, Pilcher DV, Levvey B

(2021), Transpl Int, 34(5), 906-15

DOI: 10.1111/tri.13862

Untargeted metabolomics of human plasma reveal lipid markers unique to chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis

Nambiar S, Tan DBA, Clynick B, Bong SH, Rawlinson C, Gummer J, Corte TJ, Glaspole I, Moodley YP, Trengove R

(2021), PROTEOM CLIN APPL, 15(2-3), e2000039

DOI: 10.1002/prca.202000039

Exacerbations of COPD

Man WD-C, Jones AW

(2021), In: Holland AE, Dal Corso S, Spruit MA (eds). Pulmonary Rehabilitation (ERS Monograph). Sheffield, European Respiratory Society, 165-81

DOI: 10.1183/2312508X.10018320

Community Participation by People with Chronic Obstructive Pulmonary Disease

Malaguti C, Holland AE, McDonald CF, Mahal A, Alison JA, Hill CJ, Zanaboni P, O'Halloran P, Bondarenko J, Macdonald H, Barker K, Crute H, Mellerick C, Wageck B, Boursinos H, Lahham A, Nichols A, Czupryn P, Burge AT, Cox NS

(2021), COPD, 18(5), 533-40

DOI: 10.1080/15412555.2021.1966761

Association between ambient air pollution and development and persistence of atopic and non-atopic eczema in a cohort of adults

Lopez DJ, Lodge CJ, Bui DS, Waidyatillake NT, Su JC, Perret JL, Knibbs LD, Erbas B, Thomas PS, Hamilton GS, Thompson BR, Abramson MJ, Walters EH, Dharmage SC, Bowatte G, Lowe AJ

(2021), Allergy, 76(8), 2524-34

DOI: 10.1111/all.14783

Interstitial lung disease and obstructive sleep apnea

Khor YH, Ryerson CJ, Landry SA, Howard ME, Churchward TJ, Edwards BA, Hamilton GS, Joosten SA

(2021), Sleep Med Rev, 58, 101442

DOI: 10.1016/j.smrv.2021.101442

Nocturnal hypoxaemia in interstitial lung disease: a systematic review

Khor YH, Ng Y, Sweeney D, Ryerson CJ

(2021), Thorax, 76(12), 1200-8

DOI: 10.1136/thoraxjnl-2020-216749

Chronic thromboembolic pulmonary hypertension in Australia and New Zealand: An analysis of the PHSANZ registry

Kearney K, Gold J, Corrigan C, Dhital K, Boshell D, Haydock D, McGiffin D, Wilson M, Collins N, Cordina R, Dwyer N, Feenstra J, Lavender M, Wrobel J, Whitford H, Williams T, Keating D, Whyte K, McWilliams T, Keogh A, Strange G, Kotlyar E, Anderson J, Lau EM

(2021), Respirology, 26(12), 1171-80

DOI: 10.1111/resp.14162

Exercise oscillatory ventilation during autonomic blockade in young athletes and healthy controls

Jeklin AT, Sully F, Flannery D, Naughton MT, Macefield VG, Nilsen K, Ellis MJ, La Gerche A

(2021), Eur J Appl Physiol, 121(9), 2499-2507

DOI: 10.1007/s00421-021-04720-6

Inhibition of NF-κB by ACT001 reduces fibroblast activity in idiopathic pulmonary fibrosis

Jaffar J, Glaspole I, Symons K, Westall G

(2021), Biomed Pharmacother, 138, 111471

DOI: 10.1016/j.biopha.2021.111471

Pulmonary rehabilitation for interstitial lung disease: Referral and patient experiences

Hoffman M, Mellerick C, Symons K, Glaspole I, Holland AE

(2021), CHRON RESP DIS, 18, 14799731211046022

DOI: 10.1177/14799731211046022

Publication Details